A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)

NCT06500026 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

722

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: BL-B01D1
DRUG: Topotecan

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]